Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Stock Symbol
-
CRNX on Nasdaq
James Hassard - trading volume in the past year for Crinetics Pharmaceuticals, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
29.3K |
$1.29M |
$44.08 |
Jul 5, 2024 |
Direct |
|
|
| Stock option (Right to Buy) |
130K |
|
|
Jul 5, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.